| Renal Denervation in ADPKD- RDN-ADPKD Study (NCT05460169) | University of Erlangen-Nürnberg Medical School | 2022-06-14 |
| Intrarenal Microvasculature in ADPKD (NCT05288998) | Mayo Clinic | 2021-11-30 |
| A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD (NCT05193981) | Mayo Clinic | 2021-09-14 |
| A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (NCT04578548) | Lakefront Biotherapeutics NV | 2020-11-10 |
| NOX4 and Related Biomarkers in ADPKD (NCT04630613) | Mayo Clinic | 2020-07-21 |
| Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (NCT04344769) | Mayo Clinic | 2019-10-04 |
| Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease (NCT04284657) | University of Southern California | 2019-01-30 |
| Tolvaptan-Octreotide LAR Combination in ADPKD (NCT03541447) | Mario Negri Institute for Pharmacological Research | 2018-12-12 |
| ADPKD Alterations in Hepatic Transporter Function (NCT03717883) | University of North Carolina, Chapel Hill | 2018-09-17 |
| The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (NCT03487913) | Palladio Biosciences | 2018-09-14 |
| Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository (NCT03901521) | Weill Medical College of Cornell University | 2018-06-01 |
| ADPKD and Peritoneal Dialysis: How Anticipate Peritoneal Pressure? (NCT03970018) | CHU de Reims | 2017-12-01 |
| Assessment of Longitudinal Changes in Endothelial Function and Oxidative Stress in Normotensive Patients With ADPKD (NCT03493802) | Mayo Clinic | 2017-11-01 |
| The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain (NCT02746419) | University of Chicago | 2016-12-01 |
| A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe (NCT02848521) | Otsuka Pharmaceutical Europe Ltd | 2016-10-01 |
| Efficacy of Tolvaptan on ADPKD Patients (NCT02729662) | Kyorin University | 2016-10-01 |
| High Water Intake in Polycystic Kidney Disease (NCT02933268) | Cambridge University Hospitals NHS Foundation Trust | 2016-09-26 |
| Effect of the Aquaretic Tolvaptan on Nitric Oxide System (NCT02527863) | Regional Hospital Holstebro | 2015-02-01 |
| The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients (NCT02134899) | Assistance Publique - Hôpitaux de Paris | 2014-10-14 |
| Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease (NCT02160145) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2014-05-01 |
| Clinical Implications of DNA Analysis on ADPKD (NCT02322385) | Kyorin University | 2014-01-01 |
| Repository Study of Autosomal Dominant Polycystic Kidney Disease (NCT01988038) | The Rogosin Institute | 2013-11-01 |
| Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control (NCT01932450) | Mei changlin | 2013-08-01 |
| The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe (NCT02187432) | Andreas L. Serra | 2013-08-01 |
| A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD) (NCT01810614) | University of Kansas | 2013-02-01 |
| Pasireotide LAR in Severe Polycystic Liver Disease (NCT01670110) | Mayo Clinic | 2012-08-01 |
| 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD) (NCT01451827) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2011-10-01 |
| Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency (NCT01377246) | Mario Negri Institute for Pharmacological Research | 2011-05-01 |
| Efficacy Study of Water Drinking on PKD Progression. (NCT01348035) | Kyorin University | 2011-04-01 |
| Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (NCT01336972) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2010-10-01 |
| Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD (NCT01210560) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2010-10-01 |
| Analysis of Clinical and Molecular Genetic Data Influencing the Evolution and Response to Therapy of ADPKD Patients (Autosomal Dominant Polycystic Kidney Disease) (NCT02887729) | University Hospital, Brest | 2010-06-01 |
| National Registry of Rare Kidney Diseases (NCT06065852) | UK Kidney Association | 2009-11-06 |
| A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002] (NCT01022424) | Otsuka Pharmaceutical Co., Ltd. | 2009-11-01 |
| Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to Therapy (NCT00920309) | Yale University | 2009-06-01 |
| Effects of Somatostatin on ADPKD Heart (NCT02119013) | Federico II University | 2009-01-01 |
| Effects of Somatostatin on Liver in ADPKD (NCT02119052) | Federico II University | 2009-01-01 |
| Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD) (NCT00759369) | University of Kansas | 2008-09-01 |
| Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease (NCT00414440) | Novartis Pharmaceuticals | 2006-12-01 |
| Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease (NCT00598377) | Istanbul University | 2006-09-01 |
| A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001] (NCT00841568) | Otsuka Pharmaceutical Co., Ltd. | 2006-04-01 |
| Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (NCT01039987) | University of Pittsburgh | 1999-09-01 |
| ADPKD Cohort Study (NCT02084849) | Emory University | 1998-06-01 |